RWLK REWALK ROBOTICS LTD

ReWalk Robotics to Report Third Quarter 2022 Financial Results on November 7, 2022

ReWalk Robotics to Report Third Quarter 2022 Financial Results on November 7, 2022

MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Oct. 31, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2022 financial results on Monday, November 7, 2022, at 8:30 AM Eastern time.

Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call to discuss the results as follows:

Time8:30 A.M EST
Toll free (U.S.)1-833-630-1956
International (U.S)1-412-317-1837
Germany0800-6647650
Israel1-80-9212373
Access CodePlease request to be connected to ReWalk Robotics Ltd. call
Webcast (live and replay)

under the ‘Investors’ section'.

        

The archived webcast will be available via the following link  or through the 'Investors' section' on . 

About ReWalk Robotics Ltd.

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.  ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit .

ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States. 

Investor Contact:

Michael Lawless

Chief Financial Officer

ReWalk Robotics Ltd.

T:

E: 

 



EN
31/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on REWALK ROBOTICS LTD

 PRESS RELEASE

Lifeward Names Mark Grant as New CEO

Lifeward Names Mark Grant as New CEO Industry veteran brings 30 years of commercial leadership experience MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Mark Grant has been appointed as the Company’s new President and Chief Executive Officer, effective June 2, 2025. Larry Jasinski, Lifeward’s outgoing CEO, will serve as Co-CEO and, as previously announc...

 PRESS RELEASE

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

Lifeward to Present at Sidoti Virtual Investor Conference on May 21 MARLBOROUGH, Mass., and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward, Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Larry Jasinski, Chief Executive Officer, will make a corporate presentation and host one-on-one meetings with investors at the Sidoti May Virtual Investor Conference, taking place on May 21-22, 2025. Joining him will be Mike Lawless, Chief...

 PRESS RELEASE

Lifeward Ltd. Reports First Quarter 2025 Financial Results

Lifeward Ltd. Reports First Quarter 2025 Financial Results U.S. pipeline of ReWalk opportunities continues to build with over 120 qualified leads in process Closure of AlterG sites and resulting consolidation of resources and reduced expenditures yields improved operating expense trend Second consecutive quarter of AlterG revenue growth over 15% reflecting continued sales momentum MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the l...

 PRESS RELEASE

Lifeward Completes Research Program with Israeli Human-Robot Interacti...

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons Three-year program examined opportunities to integrate artificial intelligence technology into future generations of ReWalk Exoskeletons MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced the Company has completed its research prog...

 PRESS RELEASE

Lifeward to Report First Quarter 2025 Financial Results on May 15, 202...

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a  global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its first quarter 2025 financial results before the markets open on Thursday, May 15, 2025. Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will host a conference call and liv...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch